[{"Assets_0_Q1_USD":322256000.0,"CommonStockSharesOutstanding_0_Q1_shares":50226397.0,"EarningsPerShareBasic_1_Q1_USD":0.21,"EarningsPerShareDiluted_1_Q1_USD":0.19,"NetIncomeLoss_1_Q1_USD":10297000.0,"StockholdersEquity_0_Q1_USD":206064000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":52764442.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":50158634.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS INC","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170509"}]